Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-007316-29Phase 2Completed
Phase 2 trial of prednisone in asthma (2 arms), sponsored by Nitec Pharma. Primary endpoint: Nocturnal awakenings. Started Mar 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-007316-29.